BioSpace News Archive

Genetown

KCR Expands its Service Portfolio with Trial Execution Consulting

KCR is extending its service portfolio with Trial Execution Consulting to support clients in translating scientific objectives into operational activity.

July 5, 2018
·
2 min read
Business

NanoSphere Health Sciences To Report Revenue and Significant Sales Growth in Second Quarter

Biotech leader increases cannabis brand sales in Colorado by 35 percent ahead of California launch

July 5, 2018
·
5 min read
Business

Dr. Reddy’s to Release Q1 FY19 Results on July 26, 2018

Earnings call slated for July 26, 6:30 PM IST / 9:00 AM EDT

July 5, 2018
·
3 min read
Pharm Country

Thomas Jefferson University Launches the Nation’s Only University-Based Cannabis Science Graduate Certificate Programs to Prepare Healthcare and Industry Professionals for the Fast-Growing Field

With 30 states now allowing the use of medical marijuana, the multi-billion dollar legal cannabis industry is projected to be one of the fastest-growing sectors of the U.S. economy in the next decade.

July 5, 2018
·
5 min read
Policy

Nox Medical Obtains Permanent Injunction Against Natus

Nox Medical has achieved another major milestone in its litigation with Natus Neurology.

July 5, 2018
·
1 min read
Policy

Drug Manufacturers Continue to Significantly Increase Prescription Drug Prices

Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt released the following statement on reports of yet another round of massive price hikes by drug manufacturers.

July 5, 2018
·
1 min read
Deals

Middlefield Healthcare & Life Sciences Dividend Fund Distributions for Third Quarter of 2018

Middlefield Healthcare & Life Sciences Dividend Fund is pleased to announce that distributions for the third quarter of 2018

July 5, 2018
·
2 min read
Drug Development

BioArctic Announces Positive Topline Results of BAN2401 Phase 2b at 18 Months in Early Alzheimer’s Disease

The full 18 month analysis of the 856 patient BAN2401 Phase 2b clinical study in early Alzheimer’s disease demonstrated statistically significant and dose-dependent slowing in clinical decline and reduction of amyloid beta accumulated in the brain

July 5, 2018
·
9 min read
Business

Neovii & Mundipharma Confirm In-licensing Agreement for the Development and Promotion of Grafalon(R) in China and Japan for Solid Organ & Stem Cell Transplant

Neovii pharmaceuticals AG and Mundipharma have entered into an agreement giving Mundipharma the rights to develop and distribute its polyclonal antibody immunosuppressant Grafalon®, in China and Japan from end October.

July 5, 2018
·
3 min read
Policy

European Commission Approves Expanded Indication for Sprycel (dasatinib) to Include Treatment of Children with Philadelphia Chromosome-Positive Chronic Myeloid Leukemia in Chronic Phase

Approval includes the first powder for oral suspension formulation of a tyrosine kinase inhibitor developed for administration in pediatric patients

July 5, 2018
·
18 min read